Leslie Orne is the President & CEO and Board Member of Trinity Life Sciences and premier thought leader to executives in the biopharma industry. She oversees the strategic direction of the company and has been a critical advisor to hundreds of customers across thousands of projects in her over 20-year tenure. Her support for billions of dollars in strategic transactions and the launches of dozens of products gives Leslie a unique vantage point on the industry, and her evidence-forward approach to strategic questions empowers customers to make smart, informed and timely decisions.
The ability to take a drug to market is an important milestone, but it is not the entire picture. To truly move the needle, both clinically and commercially, biopharma companies must fine-tune their teams, approaches and incentives to produce unique and innovative products.